These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14686876)

  • 1. Elevated secretory non-pancreatic type II phospholipase A2 serum activity is associated with impaired endothelial vasodilator function in patients with coronary artery disease.
    Fichtlscherer S; Kaszkin M; Breuer S; Dimmeler S; Zeiher AM
    Clin Sci (Lond); 2004 May; 106(5):511-7. PubMed ID: 14686876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
    Fichtlscherer S; Breuer S; Heeschen C; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2004 Jul; 44(1):44-9. PubMed ID: 15234404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease.
    Fichtlscherer S; Rosenberger G; Walter DH; Breuer S; Dimmeler S; Zeiher AM
    Circulation; 2000 Aug; 102(9):1000-6. PubMed ID: 10961964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient.
    Fichtlscherer S; Breuer S; Zeiher AM
    Circulation; 2004 Oct; 110(14):1926-32. PubMed ID: 15451794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease.
    Higashi Y; Goto C; Hidaka T; Soga J; Nakamura S; Fujii Y; Hata T; Idei N; Fujimura N; Chayama K; Kihara Y; Taguchi A
    Atherosclerosis; 2009 Oct; 206(2):604-10. PubMed ID: 19410250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease.
    Fichtlscherer S; Breuer S; Schächinger V; Dimmeler S; Zeiher AM
    Eur Heart J; 2004 Aug; 25(16):1412-8. PubMed ID: 15321699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
    Fichtlscherer S; Dimmeler S; Breuer S; Busse R; Zeiher AM; Fleming I
    Circulation; 2004 Jan; 109(2):178-83. PubMed ID: 14662709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease.
    Kang SM; Chung N; Kim JY; Koo BK; Choi D; Jang Y; Cho SY
    Echocardiography; 2002 Nov; 19(8):661-7. PubMed ID: 12487635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery disease.
    Kugiyama K; Ota Y; Takazoe K; Moriyama Y; Kawano H; Miyao Y; Sakamoto T; Soejima H; Ogawa H; Doi H; Sugiyama S; Yasue H
    Circulation; 1999 Sep; 100(12):1280-4. PubMed ID: 10491371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease.
    Anderson R; Dart AM; Starr J; Shaw J; Chin-Dusting JP
    Atherosclerosis; 2004 Feb; 172(2):345-51. PubMed ID: 15019545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Liu PY; Li YH; Tsai WC; Chao TH; Tsai LM; Wu HL; Chen JH
    Eur Heart J; 2003 Oct; 24(20):1824-32. PubMed ID: 14563341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin.
    Belhassen L; Pelle G; Dubois-Rande JL; Adnot S
    J Am Coll Cardiol; 2003 Apr; 41(7):1198-204. PubMed ID: 12679222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum phosphorus levels are associated with endothelial dysfunction in hypertensive patients.
    Perticone M; Maio R; Sciacqua A; Cimellaro A; Andreucci M; Tripepi G; Zoccali C; Sesti G; Perticone F
    Nutr Metab Cardiovasc Dis; 2016 Aug; 26(8):683-8. PubMed ID: 27105871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular insulin response is preserved in non-diabetic patients with coronary artery disease, despite endothelial dysfunction.
    Ihlemann N; Rask-Madsen C; Køber L; Torp-Pedersen C
    Scand Cardiovasc J; 2004 Mar; 38(1):22-7. PubMed ID: 15204243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in plasma levels of secretory type II phospholipase A(2) in patients with coronary spastic angina.
    Kugiyama K; Ota Y; Kawano H; Soejima H; Ogawa H; Sugiyama S; Doi H; Yasue H
    Cardiovasc Res; 2000 Jul; 47(1):159-65. PubMed ID: 10869542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired endothelium-dependent and -independent vasodilation in elderly patients with chronic heart failure.
    Morgan DR; Dixon LJ; Hanratty CG; Hughes SM; Leahey WJ; Rooney KP; Johnston GD; McVeigh GE
    Eur J Heart Fail; 2004 Dec; 6(7):901-8. PubMed ID: 15556052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Close relationship between the vasodilator response to acetylcholine in the brachial and coronary artery in suspected coronary artery disease.
    Takase B; Hamabe A; Satomura K; Akima T; Uehata A; Ohsuzu F; Ishihara M; Kurita A
    Int J Cardiol; 2005 Oct; 105(1):58-66. PubMed ID: 16207546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.
    Fichtlscherer S; Rössig L; Breuer S; Vasa M; Dimmeler S; Zeiher AM
    Circulation; 2001 Dec; 104(25):3023-5. PubMed ID: 11748093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease).
    Makita S; Nakamura M; Murakami H; Komoda K; Kawazoe K; Hiramori K
    Circulation; 1996 Nov; 94(9 Suppl):II211-5. PubMed ID: 8901748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.